VitalHub Expands Portfolio with MedCurrent Acquisition

VitalHub Completes Acquisition of MedCurrent Corporation

VitalHub Corp. (TSX: VHI, OTCQX: VHIBF) is excited to announce the completion of its acquisition of MedCurrent Corporation, a move that is poised to enhance its suite of healthcare solutions significantly.

Understanding MedCurrent's Contributions

MedCurrent, headquartered in Toronto, is a pioneer in Clinical Decision Support systems, focused on ensuring the appropriateness of medical imaging orders. Their flagship product, OrderWise, plays a crucial role in integrating evidence-based guidelines directly at the point of care, making it an invaluable resource for healthcare providers. MedCurrent's impressive reach extends to over 80 customers across Canada, the UK, the US, and Australia.

Enhancing Healthcare Delivery

The acquisition is in line with VitalHub's strategic vision of incorporating innovative technology solutions that aim to streamline healthcare delivery. MedCurrent's OrderWise platform is expected to complement VitalHub's Patient Flow software suite, creating a comprehensive solution that enhances market positioning. This synergistic approach is likely to open up new business opportunities and strengthen VitalHub's product offerings.

Financial Overview of the Acquisition

VitalHub has acquired MedCurrent in an all-cash transaction valued at $12 million. Following adjustments for working capital, the net up-front consideration stands at $8.3 million. Furthermore, an additional conditional earn-out of up to $21.9 million is possible, subject to performance metrics over the next three years. For the financial year ending August 31, 2024, MedCurrent reported estimated revenues of $2.7 million alongside an impressive Annualized Recurring Revenue of approximately $2.3 million at the time of the acquisition.

Leadership Insights and Future Goals

Dan Matlow, CEO of VitalHub, expressed enthusiasm about the deal, stating, "Welcoming the MedCurrent team to the VitalHub family marks a significant step in our journey. The blend of our teams will spur innovation and underpin our commitment to addressing market evolution. We eagerly anticipate the integration of MedCurrent's technology, which will enhance our value proposition for clients."

Company Advisors and Support

Essential legal assistance for this transaction was provided by Torkin Manes LLP, while financial advisory roles were filled by Morrison Park Advisors in Toronto and IMAP Netherlands in Rotterdam for MedCurrent. Norton Rose Fulbright Canada LLP offered legal support to MedCurrent.

About MedCurrent Corporation

MedCurrent is dedicated to elevating care quality and managing health system expenditures through its innovative Clinical Decision Support platform. Their system provides real-time, evidence-based guidelines, thereby improving healthcare delivery. With a small and dedicated team of 15 members operating in Canada and the UK, MedCurrent continues to forge partnerships across various healthcare organizations.

About VitalHub Corporation

VitalHub is a transformative software provider committed to empowering Health and Human Services in optimizing user experiences and healthcare outcomes. The company caters to a diverse clientele, including hospitals, health authorities, long-term care facilities, and more, across several countries.

VitalHub’s Comprehensive SaaS Offerings

VitalHub boasts an extensive suite of Software as a Service (SaaS) solutions that include:

• Electronic Health Records (EHR) and Case Management
• Patient Flow and Operational Visibility
• Workforce Automation & Compliance

The company’s growth strategy emphasizes both organic expansion in its product suite and an aggressive approach to mergers and acquisitions. VitalHub proudly serves over 1,000 clients in regions including Canada, the US, UK, Australia, the Middle East, and Europe, affirming its strong market presence.

Global Reach and Team

Headquartered in Toronto, Canada, VitalHub also benefits from an offshore development hub located in Sri Lanka. The company has built a global team of over 400 dedicated professionals who work collaboratively towards achieving strategic goals in healthcare technology.

Frequently Asked Questions

What was the main reason for VitalHub's acquisition of MedCurrent?

The acquisition aligns with VitalHub's strategic vision to enhance healthcare delivery through innovative technology solutions.

What is the OrderWise platform?

OrderWise is MedCurrent's flagship product focused on integrating evidence-based guidelines at the point of care to improve medical imaging orders.

How much did VitalHub pay for MedCurrent?

VitalHub acquired MedCurrent for a total purchase price of $12 million, with a net up-front consideration of $8.3 million.

How does this acquisition benefit VitalHub's customers?

The integration of MedCurrent's technology enhances VitalHub's existing offerings, providing a more comprehensive solution for healthcare providers and improving patient outcomes.

What is VitalHub's market focus?

VitalHub focuses on providing software solutions for Health and Human Services, serving a diverse range of clients across several geographic regions.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.